Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZM9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,115
Award facts
- Contract value 100% obligated
- $82,114.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $82,114.92 from the Defense Logistics Agency (DLA) on January 8, 2026, for Orencia Clickject 125 mg/ml, a rheumatoid arthritis treatment. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 9, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 31, 2031, that serves as the primary mechanism for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order demonstrates AmerisourceBergen's ongoing role as a critical vendor within the DLA's pharmaceutical supply chain, leveraging its position as a prime contractor on the DLA Troop Support Medical IDC to fulfill specialized medical procurement needs for military treatment facilities and federal healthcare systems. The contract reflects typical procurement patterns for the company, which competes on a full and open basis for federal contracts and delivers a diverse range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support defense and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F0ZM9?
SPE2DR26F0ZM9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F0ZM9 worth?
The government has obligated $82,115 on SPE2DR26F0ZM9.
Is contract SPE2DR26F0ZM9 an order under another contract?
Yes. SPE2DR26F0ZM9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZM9 competed?
The extent of competition for SPE2DR26F0ZM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award